Pregabalin Oral Disintegrating Tablets 50 mg (Pregabalin)

Adult dosage

This medication, consisting of pregabalin, should be taken orally in divided doses twice daily without regard to food, placed on the tongue to disintegrate and swallowed without water. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg once daily; may be increased to 300 mg once daily after 3 to 7 days, with potential further titration to a maximum of 600 mg every 7 days if necessary. - Central neuropathic pain

Children's dosage

The safety and efficacy data for children under 12 years of age and adolescents aged 12-17 are insufficient, and therefore administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so if symptoms of depression or mood changes occur during treatment, it must be reported to a healthcare professional immediately. It should not be used if there is an allergy to this medication's components. Diabetic patients may need to adjust their blood sugar control medications due to weight gain after taking this medication. If allergic reactions such as angioedema occur, discontinue use immediately and consult a healthcare professional. Elderly patients need to be cautious of falls or injuries due to dizziness or drowsiness and should refrain from activities if these symptoms occur. This medication may cause blurred vision, so any changes in vision should be reported to a healthcare professional. Halting this medication suddenly can cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be gradually reduced after consulting a healthcare professional. Patients with a history of drug abuse should be especially cautious of misuse or dependence on this medication. Patients with decreased kidney function may require dose adjustments of this medication. Patients with severe heart disease should use this medication cautiously and consult a healthcare professional immediately if symptoms of heart failure occur. Taking this medication with other central nervous system depressants or opioid analgesics can increase the risk of respiratory depression, so caution is needed. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant should consult a healthcare professional before taking this medication and use effective contraception. Breastfeeding women should discuss with a healthcare professional regarding the potential transfer of this medication into breast milk and its effects on the infant. It is advisable to avoid dangerous activities such as driving or operating machinery until dizziness or drowsiness symptoms subside. Severe skin reactions may occur, so if symptoms such as rash, redness, or blisters arise, discontinue use immediately and inform a healthcare professional. In cases of overdose, symptoms such as drowsiness, confusion, depression, and seizures may occur, so immediate medical attention should be sought for appropriate treatment. This medication must be stored out of reach of children and should not be transferred to other containers for safety.

Serious side effects

• Hives
• severe swelling (edema)
• breathing difficulties
• skin peeling
• pain in mouth/eye mucosa
• skin or eyes turning yellow (jaundice)
• severe lethargy
• sudden and severe headaches
• seizures
• confusion

Mild side effects

• Dizziness
• drowsiness
• nasopharyngitis
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• spatial disorientation
• irritability
• depression

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance

Yellow round oral disintegrating tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]